Erratum: Will PI3K pathway inhibitors be effective as single agents in patients with cancer?

Oncotarget. 2018 Aug 17;9(64):32400. doi: 10.18632/oncotarget.26017.

Authors

Joan T Garrett¹, Anindita Chakrabarty¹, Carlos L Arteaga^{1

2

3}

Affiliations

¹ Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA.
² Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA.
³ Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.409.].

Publication types

Published Erratum